| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −0.3× | −1.8× | |
| Price / Book | 0.2× | 2.1× | |
| Price / Sales | 133.7× | 4.0× | |
| Price / Free cash flow | −0.3× | −1.6× | |
| EV / EBITDA | 0.7× | −1.2× | |
| Earnings yield | −302.4% | −14.0% | |
| Free cash flow yield | −293.7% | −9.5% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,283.19 | −1.80% | $1.21T | 59.6× | 77.8% | +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $263.55 | −1.52% | $634.45B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $283.92 | −0.45% | $501.72B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $423.30 | −0.40% | $379.95B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.10 | −2.13% | $355.52B | 19.9× | 34.7% | +68.0% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $155.23 | −0.67% | $279.72B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $170.63 | −1.12% | $264.63B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $667.76 | −1.30% | $246.9B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $442.75 | −1.01% | $239.36B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.61 | −0.37% | $194.19B | 22.9× | 37.5% | +26.7% |
